How do we take on and resolve vein-related pelvic pain in women? PeVD has been associated with venous-origin chronic pelvic ...

A review of the hemorrhoid artery embolization technique, clinical outcomes, and patient ­selection considerations.

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.

Detailed price information for Trisalus Life Sciences Inc (TLSI-Q) from The Globe and Mail including charting and trades.

A new South Georgia clinic offers minimally invasive specialty care locally, so patients don't have to drive hours to Atlanta ...

Patient families often think that there are no complications when a pacemaker’s battery is low, so they anticipate an easy swap of the pacemaker from .

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

• The incidence of no-reflow was significantly higher in the thrombectomy group (1.4% vs 0.2%), which researchers attributed ...

Significant negative impact expected from the situation in Raleigh on revenue, profitability, cash generation and group indebtedness with a probable risk of covenant breach on June 30, 2026 No ...

Q4 2025 earnings call recap: 60% revenue growth, 2026 guidance of $60–$62M, PEDD/TriNav expansion, funding and risks—read now.

It’s one of those days. You are on a period and it is heavy and painful. You are not feeling one hundred percent and you don’t want to go into work. .